Answers are grounded in this paper and cite their sources.
Shows improved overall survival with immunotherapy in extensive-stage small cell lung cancer, suggesting a need for better implementation.
Compared with conventional chemotherapy, ICI therapy was associated with increased overall survival in patients with ES-SCLC. However, clinical implementation of ICI therapy was delayed, particularly in older patients.
No takes yet. Share an insight, caveat, or question.
Ihara et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: